Fifth Third Bancorp Catalyst Pharmaceuticals, Inc. Transaction History
Fifth Third Bancorp
- $25.9 Billion
- Q1 2025
A detailed history of Fifth Third Bancorp transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 650 shares of CPRX stock, worth $15,242. This represents 0.0% of its overall portfolio holdings.
Number of Shares
650
Previous 438
48.4%
Holding current value
$15,242
Previous $9,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CPRX
# of Institutions
359Shares Held
98.6MCall Options Held
13.4KPut Options Held
11.7K-
Black Rock Inc. New York, NY18.7MShares$438 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$198 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$136 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.13MShares$73.5 Million1.62% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.01MShares$70.7 Million0.02% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.41B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...